Primary Recipient

CELLERANT THERAPEUTICS, INC.

Amount

$500,000.00

Award Date

9/17/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Cellerant Therapeutic's goal is to develop an universal off-the shelf cellular therapeutic of megakaryocyte progenitors (MKP) for the mitigation of irradiation induced thrombocytopenia. These progenitors will be derived and expanded ex vivo from hematopoi